Literature DB >> 28752410

Infections Up to 76 Days After Stroke Increase Disability and Death.

Annastazia E Learoyd1, Lisa Woodhouse2, Laurence Shaw3, Nikola Sprigg2, Daniel Bereczki4, Eivind Berge5, Valeria Caso6, Hanne Christensen7, Ronan Collins8, Anna Czlonkowska9, Anwar El Etribi10, Tracy D Farr1, John Gommans11, Ann-Charlotte Laska12, George Ntaios13, Serefnur Ozturk14, Stuart J Pocock15, Kameshwar Prasad16, Joanna M Wardlaw17, Kevin C Fone1, Philip M Bath2, Rebecca C Trueman18.   

Abstract

Early infection after stroke is associated with a poor outcome. We aimed to determine whether delayed infections (up to 76 days post-stroke) are associated with poor outcome at 90 days. Data came from the international Efficacy of Nitric Oxide Stroke (ENOS, ISRCTN99414122) trial. Post hoc data on infections were obtained from serious adverse events reports between 1 and 76 days following stroke in this large cohort of patients. Regression models accounting for baseline covariates were used to analyse fatalities and functional outcomes (modified Rankin Scale (mRS), Barthel Index, Euro-Qol-5D) at 90 days, in patients with infection compared to those without infection. Of 4011 patients, 242 (6.0%) developed one or more serious infections. Infections were associated with an increased risk of death (p < 0.001) and an increased likelihood of dependency (measured by mRS) compared to those of all other patients (p < 0.001). This remained when only surviving patients were analysed, indicating that the worsening of functional outcome is not due to mortality (p < 0.001). In addition, the timing of the infection after stroke did not alter its detrimental association with fatality (p = 0.14) or functional outcome (p = 0.47). In conclusion, severe post-stroke infections, whether occurring early or late after stroke, are associated with an increased risk of death and poorer functional outcome, independent of differences in baseline characteristics or treatment. Not only are strategies needed for reducing the risk of infection immediately after stroke, but also during the first 3 months following a stroke. This study is registered: ISRCTN registry, number ISRCTN99414122, ClinicalTrials.gov Identifier, NCT00989716.

Entities:  

Keywords:  Disability; Glyceryl trinitrate; Infection; Stroke

Mesh:

Substances:

Year:  2017        PMID: 28752410      PMCID: PMC5818141          DOI: 10.1007/s12975-017-0553-3

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  40 in total

1.  Interrelationship among common medical complications after acute stroke: pneumonia plays an important role.

Authors:  Ruijun Ji; David Wang; Haipeng Shen; Yuesong Pan; Gaifen Liu; Penglian Wang; Yilong Wang; Hao Li; Yongjun Wang
Journal:  Stroke       Date:  2013-10-31       Impact factor: 7.914

2.  Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke.

Authors:  O Finlayson; M Kapral; R Hall; E Asllani; D Selchen; G Saposnik
Journal:  Neurology       Date:  2011-09-21       Impact factor: 9.910

3.  Functional recovery after ischemic stroke--a matter of age: data from the Austrian Stroke Unit Registry.

Authors:  M Knoflach; B Matosevic; M Rücker; M Furtner; A Mair; G Wille; A Zangerle; P Werner; J Ferrari; C Schmidauer; L Seyfang; S Kiechl; J Willeit
Journal:  Neurology       Date:  2012-01-11       Impact factor: 9.910

4.  The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial.

Authors:  Willeke F Westendorp; Jan-Dirk Vermeij; Elles Zock; Imke J Hooijenga; Nyika D Kruyt; Hans J L W Bosboom; Vincent I H Kwa; Martijn Weisfelt; Michel J M Remmers; Robert ten Houten; A H C M Tobien Schreuder; Sarah E Vermeer; Ewout J van Dijk; Diederik W J Dippel; Marcel G W Dijkgraaf; Lodewijk Spanjaard; Marinus Vermeulen; Tom van der Poll; Jan M Prins; Frederique H Vermeij; Yvo B W E M Roos; Ruud P Kleyweg; Henk Kerkhoff; Matthijs C Brouwer; Aeilko H Zwinderman; Diederik van de Beek; Paul J Nederkoorn
Journal:  Lancet       Date:  2015-01-20       Impact factor: 79.321

Review 5.  Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression.

Authors:  H Offner; A A Vandenbark; P D Hurn
Journal:  Neuroscience       Date:  2008-07-01       Impact factor: 3.590

6.  Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial.

Authors:  S Aslanyan; C J Weir; H-C Diener; M Kaste; K R Lees
Journal:  Eur J Neurol       Date:  2004-01       Impact factor: 6.089

7.  Preceding and poststroke infections in young adults with first-ever ischemic stroke: effect on short-term and long-term outcomes.

Authors:  Terttu Heikinheimo; Jenna Broman; Elena Haapaniemi; Markku Kaste; Turgut Tatlisumak; Jukka Putaala
Journal:  Stroke       Date:  2013-10-17       Impact factor: 7.914

Review 8.  Post-stroke infection: a systematic review and meta-analysis.

Authors:  Willeke F Westendorp; Paul J Nederkoorn; Jan-Dirk Vermeij; Marcel G Dijkgraaf; Diederik van de Beek
Journal:  BMC Neurol       Date:  2011-09-20       Impact factor: 2.474

Review 9.  Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6.

Authors:  William Whiteley; Caroline Jackson; Steff Lewis; Gordon Lowe; Ann Rumley; Peter Sandercock; Joanna Wardlaw; Martin Dennis; Cathie Sudlow
Journal:  PLoS Med       Date:  2009-09-08       Impact factor: 11.069

10.  Mobility and other predictors of hospitalization for urinary tract infection: a retrospective cohort study.

Authors:  Mary A M Rogers; Brant E Fries; Samuel R Kaufman; Lona Mody; Laurence F McMahon; Sanjay Saint
Journal:  BMC Geriatr       Date:  2008-11-25       Impact factor: 3.921

View more
  10 in total

1.  Mitochondrial DNA Copy Number as a Marker and Mediator of Stroke Prognosis: Observational and Mendelian Randomization Analyses.

Authors:  Michael Robert Chong; Sukrit Narula; Robert Morton; Conor Judge; Loubna Akhabir; Nathan Cawte; Nazia Pathan; Ricky Lali; Pedrum Mohammadi-Shemirani; Ashkan Shoamanesh; Martin O'Donnell; Salim Yusuf; Peter Langhorne; Guillaume Paré
Journal:  Neurology       Date:  2021-12-08       Impact factor: 9.910

Review 2.  New Insights into Stroke Prevention and Treatment: Gut Microbiome.

Authors:  Linna Zhao; Liji Yang; Yuying Guo; Jie Xiao; Junping Zhang; Shixin Xu
Journal:  Cell Mol Neurobiol       Date:  2021-02-26       Impact factor: 5.046

3.  Effect of Cannabinoid 2 Receptor Modulation on the Peripheral Immune Response in Central Nervous System Injury-Induced Immunodeficiency Syndrome.

Authors:  Saki Sultana; Ian Burkovskiy; Juan Zhou; Melanie M Kelly; Christian Lehmann
Journal:  Cannabis Cannabinoid Res       Date:  2021-03-03

Review 4.  Vinpocetine in the treatment of poststroke cognitive dysfunction: A protocol for systematic review and meta-analysis.

Authors:  Yang Liu; Yanying Yin; Qiao-Li Lu; Ying Dan; Mei-Song Xu; Ge Song; Chen Li
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

5.  Excessive antibiotics use increased in-hospital mortality in intracerebral hemorrhage patients with stroke-associated infection.

Authors:  Fei Wang; Yinghua Wang; Junfeng Shi; Lijuan Shen; Xinyu Xu; Ting-Ting Jiang; Li Wang; Qing Chang; Shanyou Hu; Xiao Wu
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

6.  Association Between Common Infections and Incident Post-Stroke Dementia: A Cohort Study Using the Clinical Practice Research Datalink.

Authors:  Caroline E Morton; Harriet J Forbes; Neil Pearce; Liam Smeeth; Charlotte Warren-Gash
Journal:  Clin Epidemiol       Date:  2020-08-21       Impact factor: 4.790

7.  Registered nurses' experiences of providing respiratory care in relation to hospital- acquired pneumonia at in-patient stroke units: a qualitative descriptive study.

Authors:  Gunilla Borglin; Miia Eriksson; Madeleine Rosén; Malin Axelsson
Journal:  BMC Nurs       Date:  2020-12-20

8.  Temporal Profile of Pneumonia After Stroke.

Authors:  Jeroen C de Jonge; Diederik van de Beek; Patrick Lyden; Marian C Brady; Philip M Bath; H Bart van der Worp
Journal:  Stroke       Date:  2021-09-14       Impact factor: 7.914

Review 9.  Prophylactic Antibiotics, the Mediator of Post-Stroke Infections: A Systematic Review.

Authors:  Andrew Ndakotsu; Revathi Myneni; Aimen Iqbal; Amit S Grewal; Ansha P Abubacker; Govinathan Vivekanandan; Harsh V Chawla; Safeera Khan
Journal:  Cureus       Date:  2021-05-16

Review 10.  State of the science in inflammation and stroke recovery: A systematic review.

Authors:  Christine Couch; Khalil Mallah; Davis M Borucki; Heather Shaw Bonilha; Stephen Tomlinson
Journal:  Ann Phys Rehabil Med       Date:  2021-11-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.